We are live on ! Find out more
PVCT.WS

PROVECTUS BIOPHARMACEUTICALS INC WTS (DE)
PVCT.WS

Delisted

PVCT.WS was delisted on the 13th of October, 2016.

4 hedge funds and large institutions have $1.21M invested in PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
+4
Holders Change %
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CAM
1
Cormorant Asset Management
Massachusetts
$480K +$457K +2,200,000 New
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$446K +$424K +2,043,405 New
SM
3
Sabby Management
Florida
$164K +$156K +749,337 New
Hudson Bay Capital Management
4
Hudson Bay Capital Management
Connecticut
$124K +$120K +577,066 New

PVCT.WS Hedge Fund Activity: Q2 2015 in Review

4 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) (PVCT.WS) for Q2 2015, worth a combined $1.21M.

Buyers outnumbered sellers: 4 funds opened new PVCT.WS positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $457K.

  • 4 institutional investors held PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) (PVCT.WS) as of Q2 2015, up from 0 in Q1 2015.
  • Funds reported $1.21M of PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) stock for Q2 2015.
  • 4 funds opened new PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) positions in Q2 2015 and 0 closed out, a net change of +4 holders.
  • The largest PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) buyer in Q2 2015 was Cormorant Asset Management, an estimated $457K added.

Based on aggregated 13F filings for Q2 2015.